COMP <GO>
PACB vs CTKB // NET PROFIT MARGIN
Pacific Biosciences of California Inc. (NASDAQ) VS. Cytek Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: PACB 1
— CTKB 6
▲ NET PROFIT MARGIN LEADER: CTKB
LAST: $2.90 (+2.47%) • MKT CAP: $901.4M
net-margins
-60.00%
LAST: $6.30 (+2.61%) • MKT CAP: $818.9M
net-margins
-33.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PACB VS. CTKB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PACB | CTKB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.60% | 51.80% | -23.20 | CTKB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -12.70% | -22.30 | CTKB | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.64% | -1.07% | -11.57 | CTKB | /fcf-yield <GO> |
| Operating Margin | -60.00% | -20.00% | -40.00 | CTKB | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | -33.00% | -27.00 | CTKB | /net-margins <GO> |
| Revenue Growth (YoY) | — | 0.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.76 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.4 | 68.7 | -2.30 | CTKB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $901.4M | $818.9M | $82.5M | PACB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PACB REV | CTKB REV | PACB GROSS % | CTKB GROSS % | PACB FCF | CTKB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $160.0M | $201.5M | 28.6% | 51.8% | -$113.9M | -$8.8M |
| FY 2024 | $154.0M | $200.5M | 24.2% | 55.4% | -$212.2M | $21.9M |
| FY 2023 | $0 | $193.0M | — | — | -$259.2M | $5.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PACB // BETA —
CTKB // BETA —